[1] 蔡文燕,严斐,董晶,等.辛伐他汀对唾液腺腺样囊性癌细胞生长及 survivin表达的影响[J].中国口腔颌面外科杂志,2016,14(3): 213-217. [2] Yotsukura M, Kinoshita T, Kohno M, et al. Survival predictors after resection of lung metastases of head or neck cancers [J]. Thorac Cancer, 2015, 6(5): 579- 583. [3] Bitarte N, Bandres E, Boni V, et al. MicroRNA-451 is involved in the self -renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells [J]. Stem Cells, 2011, 29(11): 1661-1671. [4] Ren QH, Liang JQ, Wei JJ, et al. Epithelial and stromal expression of miRNAs during prostate cancer progression [J]. Am J Transl Res, 2014, 6(4): 329-339. [5] 郭拴龙,张斌,李莹.MicroRNA-7与肿瘤关系研究进展及在口腔肿瘤中的展望[J].口腔医学研究,2015,31(12):1261-1263. [6] Yu T, Wu Y, Huang Y, et al. RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis [J]. Mol Ther, 2012, 20(2):398-407. [7] Abd Raboh NM, Hakim SA. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas [J]. Int J Clin Exp Pathol, 2015, 8(8): 9214-9222. [8] Stárek I, Salzman R, Kucerová L, et al. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma [J]. Pathol Res Pract, 2015, 211(10): 759-765. [9] Ren Q, Liang J, Wei J, et al. Epithelial and stromal expression of miRNAs during prostate cancer progression [J]. Am J Transl Res, 2014, 6(4):329-339. [10] Nass D, Rosenwald S, Meiri E, et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors [J]. Brain Pathol, 2009, 19(3): 375-383. [11] Leucci E, Zriwil A, Gregersen LH, et al. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo [J]. Oncogene, 2012, 31(49): 5081-5089. [12] Omura N, Li CP, Li A, et al. Genomewide profiling at methylated promoters in pancreatic adenocarcinoma [J]. Cancer Biol Ther, 2008, 7(7): 1146-1156. [13] Luo H, Zhang H, Zhang Z, et al. Downregulated miR-v9 and miR-433 in human gastric carcinoma [J]. J Exp Clin Cancer Res, 2009, 28: 82. [14] Laios A, O'Toole S, Flavin R, et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer [J]. Mol Cancer, 2008, 7: 35. [15] Yu T, Wu Y, Helman JI, et al. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway[J]. Mol Cancer Res, 2011, 9(2):161-172. |